🇺🇸 FDA
Pipeline program

Filgotinib

GS-US-432-4097

Phase 2 small_molecule terminated

Quick answer

Filgotinib for Noninfectious Uveitis is a Phase 2 program (small_molecule) at Lakefront Biotherapeutics NV with 1 ClinicalTrials.gov record(s).

Program details

Company
Lakefront Biotherapeutics NV
Indication
Noninfectious Uveitis
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials